642
Participants
Start Date
June 23, 2025
Primary Completion Date
July 31, 2029
Study Completion Date
July 31, 2030
TQB2102 for Injection
TQB2102 is a next-generation HER2 Antibody-Drug Conjugate drug proposed for patients with HER2 positive Recurrent/Metastatic Breast Cancer.
Docetaxel combined + Trastuzumab +Pertuzumab
Positive control.
NOT_YET_RECRUITING
Beijing Tiantan Hospital,Capital Medical University, Beijing
NOT_YET_RECRUITING
Liaoning Provincial Cancer Hospital, Shenyang
NOT_YET_RECRUITING
Affiliated Zhongshan Hospital Of Dalian University, Dalian
NOT_YET_RECRUITING
Affiliated Zhongshan Hospital Of Dalian University, Dalian
NOT_YET_RECRUITING
The first hospital of Jilin University, Changchun
NOT_YET_RECRUITING
Affiliated Cancer Hospital of Harbin Medical University, Harbin
NOT_YET_RECRUITING
Fudan University shanghai cancer center, Shanghai
NOT_YET_RECRUITING
Jiangsu Provincial People's Hospital, Nanjing
NOT_YET_RECRUITING
Anhui Provincial Cancer Hospital, Hefei
NOT_YET_RECRUITING
Anhui Provincial Hospital, Hefei
NOT_YET_RECRUITING
Cancer Hospital of Shandong First Medical University, Jinan
NOT_YET_RECRUITING
Tianjin Cancer Hospital Airport Hospital, Tianjin
NOT_YET_RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
RECRUITING
Hunan Cancer Hospital, Changsha
NOT_YET_RECRUITING
Zhongnan Hospital of Wuhan University, Wuhan
NOT_YET_RECRUITING
The Third People's Hospital of Zhengzhou, Zhengzhou
NOT_YET_RECRUITING
Puyang Oilfield General Hospital, Puyang
NOT_YET_RECRUITING
Huaihe Hospital of Henan University, Kaifeng
NOT_YET_RECRUITING
Shantou Central Hospital, Shantou
NOT_YET_RECRUITING
The First Affiliated Hospital of Xi'An Jiaoting Yniversity, Xi'an
NOT_YET_RECRUITING
Gansu Provincial Cancer Hospital, Lanzhou
NOT_YET_RECRUITING
Gansu Provincial Cancer Hospital, Lanzhou
NOT_YET_RECRUITING
The Affiliated Tumor Hospital of Xinjiang Medical University, Ürümqi
NOT_YET_RECRUITING
Shanxi Cancer Hospital, Taiyuan
NOT_YET_RECRUITING
Yuncheng Central Hospital, Shanxi Province, Yuncheng
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
INDUSTRY